Oxford vaccine team wins £1.4m to develop jab against ‘super gonorrhoea’

  30 March 2021

The Oxford University institute behind the AstraZeneca Covid vaccine has been awarded $2 million (£1.4m) to develop a jab against the increasing threat of “super gonorrhoea”. 

Researchers at the Jenner Institute believe their vaccine, one of just a handful currently in development, will prevent infections from different strains of the sexually transmitted infection (STI), including the most powerful multi-drug resistant forms that are spreading around the world. 

Further reading: The Telegraph
Author(s): Anne Gulland
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!